CareFusion and ResMed ink ventilator agreement
CareFusion and ResMed have signed a five-year agreement providing CareFusion the exclusive right to distribute the ResMed Stellar 100 and 150 non-invasive ventilators (NIV) and their related accessories into the U.S. institutional healthcare market.
San Diego-based CareFusion, a medical technology company, will now have an offering in the institutional NIV market, which is expected to grow by more than 6 percent annually. For ResMed, a San Diego-based developer of medical equipment for treating sleep-disordered breathing and other respiratory disorders, the deal provides an introduction of its new ventilation products, via CareFusion's relationships with U.S. hospitals, long-term acute care and skilled nursing facilities. CareFusion will also market and sell the Stellar 100 and 150 related accessories, including tubing and filters.
San Diego-based CareFusion, a medical technology company, will now have an offering in the institutional NIV market, which is expected to grow by more than 6 percent annually. For ResMed, a San Diego-based developer of medical equipment for treating sleep-disordered breathing and other respiratory disorders, the deal provides an introduction of its new ventilation products, via CareFusion's relationships with U.S. hospitals, long-term acute care and skilled nursing facilities. CareFusion will also market and sell the Stellar 100 and 150 related accessories, including tubing and filters.